 |
 |
【参考文献】
1 Robert W，Schrier MD，Wei Wang.Acute renal failure and sepsis.N Engl J Med,2004,351:159169.
2 Angus DC,LindeZwirble WT,Lidicker J,et al.Epidemiology of severe sepsis in the United States:analysis of incidence,outcome,and associated costs of care.Crit Care Med,2001,29:13031310.
3 Levy MM，Fink MP，Marshall JC，et al.SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference.Crit Care Med，2003，127:309315.
4 Schrier RW，Abraham WT.Hormones and hemodynamics in heart failure.N Engl J Med，1999,341:577585.
5 Boffa JJ,Arendshorst WJ.Maintenance of renal vascular reactivity contributes to acute renal failure during endotoxemic shock.J Am Soc Nephrol,2005,16:117124.
6 闫振成，贾昆霞，张建国,等.内毒素脂多糖对培养肾小管上皮细胞凋亡和增殖的影响.第三军医大学学报，2002，23：12761278.
7 Yiping Wang,Gopala K Rangan,Brayan Goodwin,et al.Lipopolysaccharide induced MCP1 gene expression in rat tubuler epithelial cells is nuclear factorkappaB dependent.Kidney int,2000,57:20112022.
8 Flierl MA，Schreiber H，HuberLang MS.The role of complement，C5a and its receptors in sepsis and multiorgan dysfunction syndrome.J Invest Surg，2006,19:255265.
9 De Vriese AS.Prevention and treatment of acute renal failure in sepsis.J Am Soc Nephrol，2004,14:793805.
10 陈建，王翔，罗向东.内毒素与血管内皮细胞结合特异性初探.第三军医大学报，2003，11：2527.
11 李晶玲，王超.内毒素血症时循环肾素血管紧张素改变的实验研究.中国危重病急救医学杂志，2006，18：9295.
12 Lemley KV.A basis for accelerated progression of diabetic nephropathy in pima indians.Kidney Int，2003,63:S38S42.
13 Kirkeboen KA,Strand A.The role of nitric oxide in sepsisan overview.Acta Anaesthesiol Scand,1999,43:275288.
14 Knotek M，Rogachev B，Wang W，et al.Endotoxemic renal failure in mice:role of tumor necrosis factor independent of inducible nitric oxide synthase.Kidney Int，2001，59 :22432249.
15 马明，朱晓云，王立蓉，等.一氧化氮合酶对早期内毒素休克猕猴肾脏的影响.中国危重病急救医学，2006，18：421424.
16 黄海华，范亚平，蒋季杰.诱导性一氧化氮合酶抑制剂在内毒素休克急性肾衰竭大鼠中的作用.中华肾脏病杂志，2002，18：299300.
17 O’mahony DS，Liles WS，Altermeier WA，et al.Mechanical ventilation interacts with endotoxemia to induce extrapulmonary organ dysfunction.Crit Care，2006,19:255265.
18 Aird WC.The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome.Blood，2003，101: 37653777.
19 Rivers E，Nguyen B，Havstad S，et al.Early goaldirected therapy in the treatment of severe sepsis and septic shock.N Engl J Med，2001,345:1368 1377.
20 何强，陈江华.脓毒症的急性肾损伤.中华肾脏病杂志,2006,22:655657.
21 Kress JP,Pohlman AS,O’Connor MF,et al.Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation.N Engl J Med，2000，42:14711477.
22 Finney SJ,Zekveld C,Elia A,et al.Glucose control and mortality in critically ill patients.JAMA，2003，290:20412047.
23 Annane D,Sebille V,Charpentier C,et al.Effect of treatment with low doses of hydrocortisone and fluidrocortisone on mortality in patients with septic shock.JAMA,2002,,288:862871.
24 Page B，VieillardBaron A，Chergui K,et al.Early venovenous baemodiariltration for sepsisrelated multiple organ failure.Critical care，2005,9:R755R763.
25 葛茂星，严刚.急性肾衰竭与脓毒症.中国急救医学，2005，25:208210.
26 Schiffl H，Lang SM，Fischer R.Daily hemodialysis and the outcome of acute renal failure.N Engl J Med，2002，346: 305310.
27 Russell JA.Management of sepsis.N Engl J Med，2006，355:16991713.
28 Yasuda H,Yuen PS,Hu X,et al.Simvastatin improves sepsisinduced mortality and acute kidney injury via renal vascular effects.Kidney Int，2006,69:15351542.
